mmcgrath

About Megan McGrath

This author has not yet filled in any details.
So far Megan McGrath has created 5 blog entries.

TrialCard Announces the Addition of More Than 500 Jobs

MORRISVILLE, NC—TrialCard Incorporated, a pioneer in access, affordability, adherence, and engagement solutions for patients and healthcare providers, announced today the expansion of its Market Access division in Morrisville, North Carolina. This growth, which further strengthens TrialCard’s position within the Market Access landscape, comes after TrialCard was selected to become the new Hub provider for a leading pharmaceutical manufacturer. The company currently employs over 600 people and will bring an additional 500 jobs to Morrisville by January 2019. “Not only have we seen tremendous success come from TrialCard’s business outcomes, we’ve seen its impact in our community,” said Morrisville Mayor [...]

2018-08-06T11:07:00+00:00August 6th, 2018|

TrialCard Announces TC Synapse Suite of Risk Mitigation & Compliance Solutions

MORRISVILLE, NC—TrialCard Incorporated announced today that it has released TC Synapse, a trusted suite of risk mitigation and compliance solutions, offered exclusively by TrialCard. TC Synapse takes years of pharmaceutical compliance experience and marries it with trusted algorithms and analytics to systematically reduce the risks associated with patient support programs.  These tools provide pharmaceutical manufacturers with peace of mind while protecting the interest of their brand(s).  Among the solutions in the suite are TrialCard’s Anti-Kickback Compliance, its Co-Pay Accumulator Program Mitigation Strategy, and its Discount Card Disruption Logic. Other tools included in the package are Pharmacovigilance Support, Claim Quality [...]

2018-05-07T17:57:36+00:00April 25th, 2018|

NC Patient Access Company Partners with the ALS Association

MORRISVILLE, NC—Each year, employees at TrialCard—a NC-based patient services company—support a philanthropic organization of their choice. The company’s only requirements in choosing the organization is that there’s a personal connection to an employee, as well as a local event to rally behind. This year, the chosen organization was the ALS Association. Amyotrophic Lateral Sclerosis (ALS) is a brain disease closely related to Parkinson’s, Alzheimer’s, and Huntington’s Diseases. Also known as Lou Gehrig’s disease, ALS targets brain cells, called motor neurons, which send messages from the brain to muscles throughout the body. As motor neurons die, a person progressively loses [...]

2018-04-12T16:22:37+00:00March 26th, 2018|

Rare Disease Day 2018: What it Means to a TrialCard Employee

The only thing that’s not rare about rare disease is the energy that the TrialCard team puts behind our 26 customers who manufacture Orphan Drugs and the patients they serve.  At TrialCard, the patient is always our bottom line and that is especially true for patients with rare disease. This year, Rare Disease Day is focused on research.  Research that brings new therapies and new hope to patients with rare disease, half of whom are children.  These patients present with common symptoms that often hide a more proliferative and degenerative disease.  Patients are left with a lower quality of [...]

2018-07-20T13:39:07+00:00February 28th, 2018|

2017: A Year to Be Grateful

In 2017, several of my co-workers experienced significant accomplishments that are worthy of noting.  Many of the accomplishments greatly benefited not only our customers and patients but also our local community. The TrialCard team was recognized for its expansion and creation of jobs in the Triangle, further establishing itself as an industry leader in healthcare, and also surpassing our fundraising goals for multiple charity organizations.Here are some examples of our continuous efforts to bring TrialCard's mission to life:Winning the Triangle Business Journal’s “Corporate Philanthropy Award”Karen Baker being named “Most Inspiring” in the Triangle Business Journal’s “Women in Business” AwardsJoe Abdalla [...]

2018-09-07T12:23:10+00:00December 20th, 2017|